News

Prof. Luca Gattinoni receives 1.250 million euros from the German Research Foundation for a Reinhart Koselleck project that aims at studying wether mesenchymal stromal cells can boost memory T cell...

An estimated 5-8 percent of the world's population suffers from an autoimmune disease. Autoimmunity is a misdirected immune response against one's own organism. This erroneous reaction is the...

The European Innovation Council has recognized the visionary thinking of the LIT scientists by awarding 3.789.472 Euros to the LIT-led international consortium of academy and industry partners. The...

LIT scientist Christian Schmidl received an award for his poster “Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor infiltrating T cells”, at the Cancer...

Immunomedicine is a topic that has recently gained great coverage and interest within the medical community and even beyond. Within this field, “Smart Cells” are considered as a generational...

“We celebrate the achievement of women, known and unknown, remembered and forgotten, who have forged the way for those of us in science […]

With these words Princess Nisreen El-Hasemite, BSc MDc MD...

During its annual meeting, on November 18th, the Leibniz Association has formally admitted the Regensburg Center for Interventional Immunology (RCI) to be part of the association, as its new Leibniz...

Michael Delacher, PhD, received the 2021 DAG-HSZT Research Award (German Working Group for Hematopoietic Stem Cell Transplantation and Cellular Therapy) for his work conducted at the RCI Immunology...

iOmx Therapeutics AG (iOmx) is a biopharmaceutical company co-founded by RCI scientists, that develops cancer therapeutics based on novel immune checkpoint targets. Iomx announced today the closing of...

RCI scientist, Mario Lecce, PhD, has received the prestigious Humboldt Research Fellowship, which addresses and supports post-doctoral researchers with outstanding qualifications.